Price target
28.55DPLN+1.85+6.97%
The 5 analysts offering 1 year price forecasts for CLNPHARMA have a max estimate of 39.00 and a min estimate of 12.00.
Analyst rating
Based on 5 analysts giving stock ratings to CLNPHARMA in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
2
Buy
0
Hold
2
Sell
0
Strong sell
1
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
Estimate
Currency: PLN
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
—
—
—
—
—
—
—
—
—
Estimate
—
—
—
—
—
—
—
—
—
Surprise
—
—
—
—
—
—
—
—
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
30.00 M
60.00 M
90.00 M
120.00 M
Reported
Estimate
Currency: PLN
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Reported
43.90 M
69.00 M
48.80 M
54.90 M
40.30 M
65.60 M
120.00 M
—
—
Estimate
49.67 M
52.40 M
52.15 M
54.10 M
48.57 M
63.20 M
60.15 M
58.10 M
—
Surprise
−11.61%
+31.68%
−6.42%
+1.48%
−17.02%
+3.80%
+99.50%
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
According to analysts, CLN price target is 28.56 PLN with a max estimate of 39.00 PLN and a min estimate of 12.00 PLN. Check if this forecast comes true in a year, meanwhile watch CLNPHARMA stock price chart and keep track of the current situation with CLN news and stock market news.
We've gathered opinions of 5 analysts rating CLN stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.